Trump Signs Executive Order to Fast-Track Psychedelic Research for Mental Health

The recent articles show that the executive order not only accelerates research but also relaxes restrictions on psychedelics like ibogaine. This shift highlights a significant policy move towards integrating psychedelics into psychiatric treatment pipelines. Watch for upcoming FDA decisions and clinical trial approvals that could reshape mental health therapies.